Related Experiment Video
Updated: Mar 7, 2026
14:56
Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
33.7K
Evaluating pharmaceutical waste disposal in pediatric units
Maria Angélica Randoli de Almeida1, Ana Maria Miranda Martins Wilson1, Maria Angélica Sorgini Peterlini1
1Universidade Federal de São Paulo, Escola Paulista de Enfermagem, São Paulo, SP, Brazil.
Revista Da Escola De Enfermagem Da U S P
|February 16, 2017
Summary
This study observed pharmaceutical waste disposal in pediatric units, finding significant amounts of antimicrobials and electrolytes discarded improperly. Proper waste management protocols are needed to reduce healthcare waste.
Area of Science:
- Environmental Health
- Hospital Pharmacy
- Pediatric Care
Background:
- Pharmaceutical waste management is a critical aspect of healthcare sustainability.
- Improper disposal of medications can lead to environmental contamination and health risks.
- Pediatric units generate specific types of pharmaceutical waste requiring careful handling.
Purpose of the Study:
- To assess and verify the practices of pharmaceutical waste disposal in pediatric healthcare settings.
- To identify the types and quantities of pharmaceutical waste generated and their disposal methods.
- To provide data for improving waste management strategies in pediatric units.
Main Methods:
- A descriptive and observational study was conducted in a university hospital's pediatric units.
- Pharmaceutical waste disposal was observed during drug preparation and administration.
- Data were collected using a pre-validated instrument at predetermined intervals.
Main Results:
- A total of 356 pharmaceutical disposals were documented across various pediatric units.
- Antimicrobials (22.7%), electrolytes (14.8%), and analgesics (14.6%) were the most frequently discarded drug classes.
- Common disposal methods included sharps containers with yellow bags (30.8%) and sink drains (28.9%).
Conclusions:
- Current pharmaceutical waste disposal practices in pediatric units require improvement.
- There is a need for enhanced team awareness and reflective practices regarding waste reduction.
- Implementing targeted strategies can significantly reduce the volume of healthcare waste.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
343
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
01:26Pharmaceutical Poisoning: Potential Scenarios
47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
405
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
01:29Drug Dosing: Infants and Children
625
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
625
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
304
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
583
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583